Australia - English - Department of Health (Therapeutic Goods Administration)

servier laboratories (australia) pty ltd - indapamide hemihydrate -

Australia - English - Department of Health (Therapeutic Goods Administration)

apotex pty ltd - indapamide hemihydrate -

New Zealand - English - Medsafe (Medicines Safety Authority)

boucher & muir (new zealand) limited t/a bnm group - hydrochlorothiazide 12.5mg; losartan potassium 50mg - film coated tablet - 50mg/12.5mg - active: hydrochlorothiazide 12.5mg losartan potassium 50mg excipient: hypromellose lactose monohydrate macrogol 4000 magnesium stearate microcrystalline cellulose pregelatinised maize starch purified talc quinoline yellow titanium dioxide - losartan hctad is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate.

Israel - English - Ministry of Health

j-c health care ltd - domperidone - tablets - domperidone 10 mg - domperidone - domperidone - motilium is indicated for the relief of the symptoms of nausea and vomiting.

Israel - English - Ministry of Health

organon pharma israel ltd., israel - hydrochlorothiazide; losartan potassium - tablets - losartan potassium 50 mg; hydrochlorothiazide 12.50 mg - losartan and diuretics - losartan and diuretics - ocsaar plus is indicated for the treatment of hypertension, for patients in whom combination therapy is appropriate. to reduce the risk of stroke in patients with hyperfension adn left ventricular hypertrophy.

Israel - English - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - film coated tablets - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections in patients of 18 years and older• respiratory infections : - uncomplicated acute bacterial sinusitis (abs) - acute exacerbations of chronic bronchitis (aecb) megaxin tablets should be used to treat adequately diagnosed abs and aecb only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed to resolve the infection. - community acquired pneumonia, except severe cases. megaxin tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection. • community-acquired spontaneous and wound infections of the skin and skin structure.appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin tablets may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Israel - English - Ministry of Health

bayer israel ltd - moxifloxacin as hydrochloride - film coated tablets - moxifloxacin as hydrochloride 0.4 g - moxifloxacin - moxifloxacin - for the treatment of the following bacterial infections in patients of 18 years and older• respiratory infections : - uncomplicated acute bacterial sinusitis (abs) - acute exacerbations of chronic bronchitis (aecb) megaxin tablets should be used to treat adequately diagnosed abs and aecb only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of these infections or when these have failed to resolve the infection. - community acquired pneumonia, except severe cases. megaxin tablets should be used only when it is considered inappropriate to use antibacterial agents that are commonly recommended for the initial treatment of this infection. • community-acquired spontaneous and wound infections of the skin and skin structure.appropriate culture and susceptibility tests should be performed before treatment in order to isolate and identify organisms causing infection and to determine their susceptibility to moxifloxacin. therapy with megaxin tablets may be initiated before results of these tests are known; once results become available, appropriate therapy should be continued.consideration should be given to official guidance on the appropriate use of antibacterial agents.

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine, indapamide, amlodipine besilate - film coated tablet - 5/1.25/10 milligram - ace inhibitors, other combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine, indapamide, amlodipine besilate - film coated tablet - 10/2.5/5 milligram - ace inhibitors, other combinations

Ireland - English - HPRA (Health Products Regulatory Authority)

les laboratoires servier - perindopril arginine, indapamide, amlodipine besilate - film coated tablet - 10/2.5/10 milligram - ace inhibitors, other combinations